S-21 Pharmaceutical Education and Regulatory Science S21-1 From a University Education for the Research and Development of the New Medicine S21-2 From a University Education for the Clinical Development of the New Medicine S21-3 Expectation of Regulatory Science Education; Administrator Perspective S21-4 Expectation of Regulatory Science Education; NDA Reviewer Perspective S21-5 Talents and Skills for the Globalizing Japanese Pharmaceutical Industry S21-6 The expectation of Regulatory Science  Education -from the viewpoint of Japanese pharmaceutical company-